Hearing loss is independently associated with substance use disorders among those aged 49 years and younger.
Compared with patients without HIV, the poorer cognitive performances of PLWHIV were partly mediated by a higher prevalence of depressive symptoms.
Physicians reported that a lack of training in brief intervention and reimbursement make providing screening and intervention more difficult when caring for youth with possible substance use disorders.
In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
From 2007 to 2016, there was an increase in the proportion of substance use treatment facilities offering medication treatment.
Investigators examined whether adolescents who use marijuana heavily develop acute psychotic symptoms at a much higher rate than youths who use marijuana minimally or not at all.
A set of characteristics of nonmedical use of prescription opioids in adolescents may help identify youth at high risk for substance use disorder, including opioid misuse, in early midlife.
Patients with chronic pain and a history of physical and sexual abuse were found to be more likely to concurrently use benzodiazepine and opioids.
The investigational fatty acid amide hydrolase inhibitor PF-04457845 may decrease cannabis withdrawal symptoms and dependence in men.
Alprazolam was found to be the most commonly misused benzodiazepine.